Form 424B7 - Prospectus [Rule 424(b)(7)]:
SEC Accession No. 0001654954-19-010771
Filing Date
2019-09-16
Accepted
2019-09-16 16:10:54
Documents
5

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS endra_424b7.htm 424B7 558159
2 IMAGE endra_s3000.jpg GRAPHIC 8920
3 IMAGE endra_s3001.jpg GRAPHIC 12818
4 IMAGE endra_s3002.jpg GRAPHIC 31048
5 IMAGE endra_s3003.jpg GRAPHIC 8953
  Complete submission text file 0001654954-19-010771.txt   644826
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

EIN.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B7 | Act: 33 | File No.: 333-233466 | Film No.: 191094847
SIC: 3845 Electromedical & Electrotherapeutic Apparatus